Author:
Liu Lei,Zheng Longbo,Liu Shanglong,Zhang Maoshen,Zhang Simeng,Jiang Zinian,Qin Chen,Wang Dongsheng
Reference42 articles.
1. Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol 2022;8(3):420–444; https://doi.org/10.1001/jamaoncol.2021.6987.
2. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
3. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence;Polom;Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group,2016
4. The patterns and timing of recurrence after curative resection for gastric cancer in China;Liu;World J Surg Oncol,2016
5. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients;Reutovich;Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol,2019